Pediatric Vaccine Limiting Through Age 23 Months Among U.S. Military Families

Celeste J Romano1, Monica T Burrell1, Clinton Hall1

  • 1Deployment Health Research Department, Naval Health Research Center, San Diego, California; Leidos, Inc., San Diego, California.

Insights

Few military parents limit early childhood vaccines, but this pattern increases undervaccination risk. Understanding vaccine hesitancy is crucial for improving vaccination rates in military families.

Area of Science:

  • Pediatric Health
  • Vaccinology
  • Public Health Policy

Background:

  • Gaps in pediatric 7-vaccine series completion exist among U.S. military families.
  • The influence of vaccine hesitancy on these vaccination gaps is not well understood.
  • This study investigates vaccine limiting as a factor in undervaccination.

Purpose of the Study:

  • To assess vaccine limiting as a determinant of undervaccination in military-connected children.
  • To identify characteristics associated with vaccine limiting behavior.

Main Methods:

  • Utilized Department of Defense Birth and Infant Health Research data (2010-2019).
  • Analyzed vaccination patterns through 23 months, categorizing frequency of limited vaccine visits (1-2 vaccines).
  • Employed modified Poisson regression to link limiting patterns with noncompletion of the 7-vaccine series by 24 months.

Main Results:

  • Prevalence of consistent vaccine limiting was 0.7%; episodic limiting was 3.6% among 275,967 children.
  • Consistent vaccine limiters more often had older parents and highly educated military sponsors.
  • Consistent and episodic limiting increased risk of noncompletion by 3.9 and 2.4 times, respectively.

Conclusions:

  • While few parents consistently or episodically limit early childhood vaccines, these behaviors are linked to increased undervaccination risk.
  • Findings highlight the need for increased focus on vaccine hesitancy within the military-connected population.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
45.3K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
448
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
Routes of Drug Administration: Parenteral01:25

Routes of Drug Administration: Parenteral

The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
2.1K